P Dufour

885 total citations
24 papers, 532 citations indexed

About

P Dufour is a scholar working on Oncology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, P Dufour has authored 24 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 6 papers in Epidemiology. Recurrent topics in P Dufour's work include Colorectal Cancer Treatments and Studies (5 papers), Acute Myeloid Leukemia Research (4 papers) and Cancer Treatment and Pharmacology (3 papers). P Dufour is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Acute Myeloid Leukemia Research (4 papers) and Cancer Treatment and Pharmacology (3 papers). P Dufour collaborates with scholars based in France, United States and Belgium. P Dufour's co-authors include Jean A. Maroun, Ullrich Graeven, Alberto Sobrero, Ronald M. Bukowski, John L. Marshall, Paulo M. Hoff, Edith P. Mitchell, G. Pérez-Manga, J Lokich and Juergen Schöelmerich and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Cancer Chemotherapy and Pharmacology.

In The Last Decade

P Dufour

23 papers receiving 507 citations

Peers

P Dufour
Comparison fields: 5 of 65
  • Oncology 385
  • Pulmonary and Respiratory Medicine 112
  • Surgery 103
  • Hematology 76
  • Pathology and Forensic Medicine 71
Replace Woo Kun Kim with:
Woo Kun Kim South Korea
Evin Büyükünal Türkiye
D. Braumann Germany
G. Piot France
Alfonso Yubero Spain
M. Beer United States
Laura Bellio Italy
M. Patrick Stagg United States
J. Peter United States
Maria Koch Canada
Woo Kun Kim South Korea View profile →
Citations per field, relative to P Dufour
P Dufour · 1×
Citations per year, relative to P Dufour
P Dufour · 1×

Countries citing papers authored by P Dufour

Since Specialization
Citations

This map shows the geographic impact of P Dufour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Dufour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Dufour more than expected).

Fields of papers citing papers by P Dufour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Dufour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Dufour. The network helps show where P Dufour may publish in the future.

Co-authorship network of co-authors of P Dufour

This figure shows the co-authorship network connecting the top 25 collaborators of P Dufour. A scholar is included among the top collaborators of P Dufour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Dufour. P Dufour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Effects of Repeated Topical Application of a 0.0584% Hydrocortisone Aceponate Spray on Skin Thickness in Beagle Dogs
5
2 18
3 2
4 2
5
Liver abscess due to clostridium septicum. A case report and review of the literature.
8
6 312
7
Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study.
24
8
[Compassionate use of gemcitabine in advanced pancreatic cancer: a French multicentric study].
6
9 10
10
Autologous bone marrow transplantation vs intensive chemotherapy in first complete remission: interim results of GOELAM study in AML.
7
11 6
12
[Breast osteosarcoma. Review of the literature and presentation of two cases].
1
13
Intraperitoneal mitoxantrone as consolidation treatment for stage III ovarian carcinoma: a pilot study.
3
14
High dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: a retrospective analysis of 35 patients treated in France.
40
15 6
16
[High doses of alkylating agents and bone marrow autograft in ovarian cancer with poor prognosis: a retrospective analysis of 40 patients treated in France].
0
17 7
18 48
19 4
20
[Mediastinal choriocarcinoma in acute myeloblastic leukemia].
3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026